Trials / Completed
CompletedNCT05407727
A Prospective, Remote Observational Study in Pediatric Participants With Early-Onset SCN2A-Developmental and Epileptic Encephalopathy
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 5 (actual)
- Sponsor
- Praxis Precision Medicines · Industry
- Sex
- All
- Age
- 1 Year – 16 Years
- Healthy volunteers
- Not accepted
Summary
This prospective observational study is designed to assess the individualized baseline disease burden in pediatric participants aged 1 year to 16 years, with early-onset SCN2A-DEE by characterizing and quantifying changes in clinical features over a period of up to 12 months.
Conditions
Timeline
- Start date
- 2022-04-15
- Primary completion
- 2023-03-31
- Completion
- 2023-03-31
- First posted
- 2022-06-07
- Last updated
- 2024-01-10
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT05407727. Inclusion in this directory is not an endorsement.